Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $17.81M.
ENTERPRISE VALUE (EV)
$17.81M
Estrella Immunopharma, Inc.
Market Cap
$19.20M
Enterprise Value (EV)
$17.81M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | $19.20M | $17.81M |
| Actuate Therapeutics Inc (ACTU)vs › | $19.54M | $15.52M |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.73M | N/A |
| NextCure, Inc. (NXTC)vs › | $18.67M | $7.70M |
| P3 Health Partners Inc. (PIII)vs › | $19.72M | $128.72M |
| Cosmos Health Inc. (COSM)vs › | $17.53M | $31.71M |
| Modular Medical, Inc. (MODD)vs › | $21.03M | $17.39M |
| PAVmed Inc. (PAVM)vs › | $17.21M | $30.49M |
| Lipocine Inc. (LPCN)vs › | $17.19M | $12.21M |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.09M | $5.76M |
Market Cap
$19.20M
Total Debt
$0.00
Cash
$1.38M
Enterprise Value
$17.81M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
